πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 252 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10941392

Purification of cystathionine beta-synthase

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10912770

Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10913790

Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10912767

Anthracycline prodrugs and methods of making and using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10889625

Peptide-based methods for treating neurological injury

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10874745

Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-pola

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10857106

Methods and products for treating and/or delaying onset of dysplastic lesions

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10799511

Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10791731

Methods for preparing frozen plasma material for rapid thawing in an emergency situation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10751408

Compositions and methods for making and using thermostable immunogenic formulations with i

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10738123

Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10736864

Immunotherapeutic agent

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10729753

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10723784

Compositions and methods for preparing a subject for organ or non-organ implantation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10689392

Anti-cancer compounds targeting ral GTPases and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10676480

Anti-cancer compounds targeting Ral GTPases and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10674901

Minimally-invasive measurement of esophageal inflammation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10653755

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10624959

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10562938

Theragnostic particles

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10548979

Light-activated compositions and methods using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10519423

High efficiency reprogramming of fibroblasts into cardiomyocytes

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10520517

Disease severity index for assessment of chronic liver disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10518002

Intraocular drug delivery and filter device and methods of using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted